Adverts

Open Access Articles- Top Results for Blosozumab

Blosozumab

</th></tr>
Blosozumab?
Monoclonal antibody
Type Whole antibody
Source Humanized (from mouse)
Target SOST
Clinical data
Identifiers
1132758-87-2 7pxN
None
KEGG D10094 7pxN
Chemical data
Formula C6462H9852N1684O2030S46
144.63 kDa
 14pxN (what is this?)  (verify)

Blosozumab binds SOST, a negative regulator of osteoblast activity. Blocking SOST activity can lead to increased bone density.[1]

Blosozumab was developed by Eli Lilly and Company.

References

  1. ^ World Health Organization (2011). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 105" (PDF). WHO Drug Information 25 (2). 


Lua error in package.lua at line 80: module 'Module:Buffer' not found. Lua error in package.lua at line 80: module 'Module:Buffer' not found.